Jasreet Hundal,  McDonnell Genome Institute

Publications

title citation publication date
Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity. Cancer Immunol Res. 2017 Jul;5(7):516-523. doi: 10.1158/2326-6066.CIR-16-0264. Epub 2017 Jun 15. 1970-08-22
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial. Ann Oncol. 2017 May 1;28(5):1070-1077. doi: 10.1093/annonc/mdx048. 1970-08-22
Genomic characterisation of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy - results from the ACOSOG Z1041 (Alliance) trial. Ann Oncol. 2017 Feb 21. doi: 10.1093/annonc/mdx048. 2017-02-21
Cancer Immunogenomics: Computational Neoantigen Identification and Vaccine Design. Cold Spring Harb Symp Quant Biol. 2017 Apr 7. pii: 030726. doi: 10.1101/sqb.2016.81.030726.
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape Cancer Immunol Res. 2017 Feb;5(2):106-117. doi: 10.1158/2326-6066.CIR-16-0391. Epub 2017 Jan 10. 2017-02-05
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas. Cell Rep. 2016 Sep 27;17(1):249-60. doi: 10.1016/j.celrep.2016.08.076. 1970-08-22
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia Exp Hematol. 2016 Jul;44(7):603-13. doi: 10.1016/j.exphem.2016.04.011. Epub 2016 May 13 2016-07-01
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens. Genome Med. 2016 Jan 29;8(1):11. doi: 10.1186/s13073-016-0264-5. 2016-01-29
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. JAMA. 2015 Aug 25;314(8):811-22. doi: 10.1001/jama.2015.9643. 2015-08-25
Genome Modeling System: A Knowledge Management Platform for Genomics. PLoS Comput Biol. 2015 Jul 9;11(7):e1004274. doi: 10.1371/journal.pcbi.1004274. eCollection 2015. 2015-07-09
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015 Apr 2. pii: aaa3828. [Epub ahead of print] 2015-04-02
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature. 2014 Nov 27;515(7528):577-81. doi: 10.1038/nature13988. 2014-11-27
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature. 2014 Dec 8. doi: 10.1038/nature13968. [Epub ahead of print] 2014-12-08
U2AF1 Mutations alter sequence specificity of pre-mRNA binding and splicing. Leukemia. 2014 Oct 14. doi: 10.1038/leu.2014.303. [Epub ahead of print] 2014-10-14
Genomic impact of transient low-dose decitabine treatment on primary AML cells. Blood. 2013 Jan 7. [Epub ahead of print] 2013-01-07
The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012 Jul 20;150(2):264-78. 2012-07-20
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature. 2012 Feb 8 [Epub ahead of print]. 2012-02-08
DNMT3A Mutations in Acute Myeloid Leukemia N Engl J Med. 2010 Nov 10. 2010-11-10